Abstract: A composition comprising an antibody or an antigen binding fragment thereof specific for at least one epitope of hsp90 from an organism of the Aspergillus genus, and at least one antifungal agent selected from the group consisting of: itraconazole and voriconazole.
Type:
Grant
Filed:
April 18, 2005
Date of Patent:
August 31, 2010
Assignee:
Neutec Pharma Limited
Inventors:
James Peter Burnie, Ruth Christine Matthews
Abstract: The present invention relates to a novel medicaments and preparations comprising effective anti-cancer agents together with an anti-Hsp90 antibody which together provide an enhanced efficacy in the treatment of cancer, and leukaemia.
Type:
Application
Filed:
June 30, 2005
Publication date:
February 14, 2008
Applicant:
NEUTEC PHARMA LIMITED
Inventors:
James Burnie, Ruth Matthews, Tracey Carter
Abstract: The present invention is concerned with compounds, medicaments and treatments for Clostridium difficile infection, together with novel isolated antibodies and their use in same. The present invention is also concerned with the treatment and prophylaxis of E. faecium and E. faecalis infection and provides medicaments and treatments for same.
Type:
Application
Filed:
July 1, 2005
Publication date:
February 14, 2008
Applicant:
NEUTEC PHARMA LIMITED
Inventors:
James Burnie, Ruth Matthews, Tracey Carter